Search Results - chapman+wright

1 Results Sort By:
Selective Prodrug Activation in Cancer Cells Using Protein Switches
Unmet Need: Gene-directed enzyme prodrug therapy (GDEPT; also known as “suicide gene therapy”) is an emerging gene therapy strategy against cancer. A prodrug is systemically administered but only activated in cancer cells that have previously been modified to express an enzyme capable of activating the drug. Yet, the clinical utility of GDEPT to date...
Published: 9/26/2024   |   Inventor(s): Chapman Wright, Marc Ostermeier
Keywords(s): Biologics, Biomarker, Cancers, Disease Indication, Gene Therapy, Mechanism-of-action Biomarker, Polypeptide, Protein, Single, Therapeutic Matter, Therapeutic Substance, Therapeutics, Therapy Type
Category(s): Clinical and Disease Specializations, Clinical and Disease Specializations > Oncology, Technology Classifications > Diagnostics > Biomarkers, Technology Classifications > Therapeutic Modalities > Biologics, Technology Classifications > Therapeutic Modalities > Peptides, Technology Classifications > Therapeutic Modalities > Targets, Technology Classifications > Diagnostics, Technology Classifications > Therapeutic Modalities, Technology Classifications > Therapeutic Modalities > Proteins, Technology Classifications > Therapeutic Modalities > Gene Therapies
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by Inteum